Cargando…
Correction to: Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type
Autores principales: | Birjandi, Shirin Z., Abduljawad, Nora, Nair, Shyama, Dehghani, Morteza, Suzuki, Kazunori, Kimura, Haruhide, Carmichael, S. Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213669/ https://www.ncbi.nlm.nih.gov/pubmed/33123953 http://dx.doi.org/10.1007/s12975-020-00858-1 |
Ejemplares similares
-
Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type
por: Birjandi, Shirin Z., et al.
Publicado: (2020) -
Translational Development Strategies for TAK-063, a Phosphodiesterase 10A Inhibitor
por: Macek, Thomas A, et al.
Publicado: (2020) -
Characterization of Binding and Inhibitory Properties of TAK-063, a Novel Phosphodiesterase 10A Inhibitor
por: Harada, Akina, et al.
Publicado: (2015) -
Author Correction: Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement
por: Suzuki, Atsushi, et al.
Publicado: (2021) -
Combined treatment with a selective PDE10A inhibitor TAK‐063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic‐like effects without affecting plasma prolactin levels and cataleptic responses in rodents
por: Suzuki, Kazunori, et al.
Publicado: (2017)